Houlihan Lokey Q1 FY27 Misses as Revenue and Earnings Decline Sharply, Validating Bearish Thesis

What happened

Houlihan Lokey reported Q1 fiscal 2027 revenue of $511 million, down 15.5% from $605 million a year ago, with net income falling to $78 million from $98 million. The double-digit declines underscore a sharp slowdown in mid-market M&A and restructuring activity, exactly the risk flagged in our prior analysis. With the majority of fees tied to success-based transaction closings, the miss directly erodes the bull case that the company could sustain mid-teens growth. The weak quarter raises the likelihood that full-year margins will compress as fixed costs and acquisition-related expenses continue to grow. Near-term catalysts are now pointing toward further disappointment, making the current stock setup unattractive.

Implication

The 15%+ revenue decline signals that the mid-market M&A environment has weakened materially, consistent with our bear case. Margins are at risk if management maintains its hiring trajectory while deal fees fall. The premium valuation—previously supported by growth expectations—is now increasingly difficult to justify. We reiterate our trim recommendation above $190 and see potential downside to $145 unless there is a quick rebound in closings. European expansion costs could further pressure profitability, reinforcing a cautious stance.

Thesis delta

Q1 FY27 results undershoot expectations sharply, validating our bear case and increasing conviction to trim above $190. The revenue decline suggests our bear scenario is playing out, with a higher probability now assigned to margin compression and multiple contraction. We see a more attractive entry opportunity near $145, but require evidence of stabilization before turning constructive.